InspireMD has launched its CGuard Prime carotid stent system in the U.S. following FDA premarket approval last month. The next-generation stent uses the company’s MicroNet mesh technology to trap embolic debris and prevent plaque prolapse, helping reduce the risk of stroke with proven durability beyond five years.
The mesh-covered, open-cell design features SmartFit technology for precise vessel wall apposition without tapered versions, improving deliverability and deployment. InspireMD’s commercial launch marks a key milestone as it expands from its established presence in over 30 countries.
Follow MEDWIRE.AI for the latest in vascular intervention innovations.
